Lawsuit Alleges Medtronic Infuse Caused Excessive Bone Growth on Spine

A Florida man has filed a lawsuit after experiencing excessive bone growth around his spine from side effects of Medtronic’s Infuse bone graft, alleging that the company illegally promoted the medical device off-label and then failed to warn about the serious risk of complications associated with using the product in ways that were never approved by the FDA as safe and effective. 

The complaint (PDF) was filed by Anthony Foster on July 27, in the U.S. District Court for the Northern District of Florida.

Medtronic Infuse is a bone morphogenetic protein (BMP), which is used to encourage bone growth and replace spinal disks by filling the gaps between vertebrae. It is promoted as an alternative to bone graft procedures where bone is harvested from another part of the body or from cadavers.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

According to allegations raised in the Medtronic Infuse lawsuit, Foster received the bone growth protein during spinal surgery in November 2007, to address degenerative disk disease and persistent back pain.

Although the FDA only approved the Infuse for use during spinal surgery that involves a single-level anterior lumbar interbody fusion (ALIF), where the spine is approached from the front, the Medtronic Infuse has been widely used for other types of spinal surgery, which have been linked to an increased risk of severe and painful complications caused by excessive or ectopic bone growth.

Foster’s surgery involved a transforaminal lumbar interbody fusion (TLIF), where the spine is approached from the back. About 16 months later, Foster’s back pain began to return, but this time included weakness and loss of sensitivity, as well as retrograde ejaculation, which causes male semen to be directed into the urinary bladder instead of out of the urethra.

Following physical therapy to address the back pain, Foster’s problems continued to get worse until he required revision surgery in August 2011. At that time, Foster learned from different physicians that his problems were caused by bone growth complications of the Medtronic Infuse.

In 2008, the FDA issued an alert about the risks associated with off-label use of Medtronic Infuse, after receiving a number of reports involving serious complications and deaths, often involving use in the cervical spine where the bone growth problems may impact the airway.

Foster’s case joins a growing number of lawsuits filed over the Medtronic Infuse bone growth protein, which have been filed in state and federal courts throughout the country. The complaints charge Medtronic with negligence, designing and manufacturing a defective product, failure to warn, breach of warranty, and fraud. Many of the lawsuits also seek punitive damages against the company for its alleged reckless behavior in Infuse illegal promotions.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted yesterday)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted 2 days ago)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).